HDAC9 is implicated in schizophrenia and expressed specifically in post-mitotic neurons but not in adult neural stem cells

American Journal of Stem Cells

Volumn 1, Issue 1, 2012, Pages 31-41

  Lang, Bing ^a   Alrahbeni, Tahani Mohammed A ^a,b   St Clair, David ^a   Blackwood, Douglas H ^c   McCaig, Colin D ^a   Shen, Sanbing ^d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Ministry of Education Saudi Arabia   (Saudi Arabia)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Adult neural stem cells; Copy number variation; HDAC9; Histone deacetylase; Neuron specific expression; Schizophrenia

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE 9; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BASOLATERAL AMYGDALA; BRAIN CORTEX; CHOROID PLEXUS; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE DELETION; GENE EXPRESSION; GLIA; HIPPOCAMPUS; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOUSE; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PYRIFORM CORTEX; SCHIZOPHRENIA;

EID: 84899842005     PISSN: None     EISSN: 21604150     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bertrand P. Inside HDAC with HDAC inhibitors. Eur J Med Chem 2010; 45: 2095-2116.
2. Khan S, Khan U. Role of histone acetylation in cell physiology and diseases: An update. Clinica Chimica Acta 2010; 411: 1401-1411.
3. Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, Qian X, Mills E, Berghs SC, Carey N, Finn PW, Collins LS, Tumber A, Ritchie JW, Jensen PB, Lichenstein HS, Sehested M. Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors. Biochem J 2008; 409: 581-589.
4. DeRuijter A, VanGennip A, Caron H, Kemp S, VanKuilenburg A. Histone deacetylases (HDACs): Characterization of the classical HDAC family. Biochem J 2003; 370: 737-749.
5. Gavin D, Sharma R. Histone modifications, DNA methylation, and schizophrenia. Neurosci Biobehav Rev 2010; 34: 882-888.
6. Seto E, Yang X. Regulation of histone deacetylase activities and functions by phosphorylation and dephosphorylation. In: Ralph A. Bradshaw, Edward A. Dennis, editors. Handbook of Cell Signaling (Second Edition). San Diego: Academic Press; 2010. pp. 2379-2388.
7. Taunton J, Hassig C, Schreiber S. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 1996; 272: 408-411.
8. Verdin E, Dequiedt F, Kasler H. Class II histone deacetylases: Versatile regulators. Trends Genet 2003; 19: 286-293.
9. Dovey OM, Foster CT, Cowley SM. Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation. Proc Natl Acad Sci U S A 2010; 107: 8242-8247.
10. Balasubramaniyan V, Boddeke E, Bakels R, Küst B, Kooistra S, Veneman A, Copray S. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. Neuroscience 2006; 143: 939-951.
11. Milde T, Oehme I, Korshunov A, Kopp-Schneider A, Remke M, Northcott P, Deubzer HE, Lodrini M, Taylor MD, von Deimling A, Pfister S, Witt O. HDAC5 and HDAC9 in medulloblastoma: Novel markers for risk stratification and role in tumor cell growth. Clin Cancer Res 2010; 16: 3240-3252.
12. Zhang X, Chen H, Jaramillo E, Wang L, D'Mello SR. Histone deacetylase-related protein inhibits AES-mediated neuronal cell death by direct interaction. J Neurosci Res 2008; 86: 2423-2431.
13. Zhou X, Marks P, Rifkind R, Richon V. Cloning and characterization of a histone deacetylase, HDAC9. Proc Natl Acad Sci U S A 2001; 98: 10572-10577.
14. Zhang C, McKinsey T, Chang S, Antos C, Hill J, Olson E. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 2002; 110: 479-488.
15. Tsankova N, Renthal W, Kumar A, Nestler E. Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 2007; 8: 355-367.
16. Renthal W, Nestler E. Histone acetylation in drug addiction. Semin Cell Dev Biol 2009; 20: 387-394.
17. Gavin D, Kartan S, Chase K, Jayaraman S, Sharma R. Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. J Psychiatr Res 2009; 43: 870-876.
18. Covington H, Maze I, LaPlant QC, Vialou VF, Ohnishi YN, Berton O, Fass DM, Renthal W, Rush AJ, Wu EY, Ghose S, Krishnan V, Russo SJ, Tamminga C, Haggarty SJ, Nestler EJ. Antidepressant actions of histone deacetylase inhibitors. J Neurosci 2009; 29: 11451-11460.
19. Takizawa D, Kakizaki S, Horiguchi N, Tojima H, Yamazaki Y, Ichikawa T, Sato K, Mori M. Histone deacetylase inhibitors induce cytochrome P450 2B by activating nuclear receptor constitutive androstane receptor. Drug Metab Dispos 2010; 38: 1493-1498.
20. Kim T, Park J, Kim H, Chung J, Kim J. Association of histone deacetylase genes with schizophrenia in korean population. Psychiatry Res 2010; 178: 266-269.
21. Gavin D, Rosen C, Chase K, Grayson D, Tun N, Sharma R. Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J Psychiatry Neurosci 2009; 34: 232-237.
22. Akbarian S, Hsien-Sung H. Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 2006; 52: 293-304.
23. Tam G, Van de Lagemaat L, Redon R, Strathdee K, Croning M, Malloy M, et al. Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem Soc Trans 2010; 38:445-51.
24. Broide R, Redwine J, Aftahi N, Young W, Bloom F, Winrow C. Distribution of histone deacetylases 1-11 in the rat brain. J Mol Neurosci 2007; 31: 47-58.
25. Lucio-Eterovic AK, Cortez MA, Valera ET, Motta FJ, Queiroz RG, Machado HR, Carlotti CG Jr, Neder L, Scrideli CA, Tone LG. Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: Class II and IV are hypoexpressed in glioblastomas. BMC Cancer 2008; 8: 243.
26. International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008; 455: 237-241.
27. Ramos-Vara J. Principles and methods of immunohistochemistry. Methods Mol Biol 2011; 691: 83-96.
28. Shi S, Key M, Kalra K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39: 741-748.
29. Prozorovski T, Schulze-Topphoff U, Glumm R, Baumgart J, Schröter F, Ninnemann O, Siegert E, Bendix I, Brüstle O, Nitsch R, Zipp F, Aktas O. Sirt1 contributes critically to the redoxdependent fate of neural progenitors. Nat Cell Biol 2008; 10: 385-394.
30. S Shen S, Li J, Casaccia-Bonnefil P. Histone modifications affect timing of oligodendrocyte progenitor differentiation in the developing rat brain. J Cell Biol 2005; 169: 577-589.
31. Morrison BE, Majdzadeh N, Zhang X, Lyles A, Bassel-Duby R, Olson EN, D'Mello SR. Neuroprotection by histone deacetylase-related protein. Mol Cell Biol 2006; 26: 3550-3564.
32. Sugo N, Oshiro H, Takemura M, Kobayashi T, Kohno Y, Uesaka N, Song WJ, Yamamoto N. Nucleocytoplasmic translocation of HDAC9 regulates gene expression and dendritic growth in developing cortical neurons. Eur J Neurosci 2010; 31: 1521-1532
33. Tremolizzo L, Doueiri MS, Dong E, Grayson DR, Davis J, Pinna G, Tueting P, RodriguezMenendez V, Costa E, Guidotti A. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 2005; 57: 500-509.
34. Flood D, Choinski M, Marino M, Gasior M. Mood stabilizers increase prepulse inhibition in DBA/2NCrl mice. Psychopharmacology (Berl) 2009; 205: 369-377.
35. Glick I, Bosch J, Casey D. A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive. J Clin Psychopharmacol 2009; 29: 267-271.
36. Schroeder F, Lin C, Crusio W, Akbarian S. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 2007; 62: 55-64.
37. Kelly D, Conley R, Feldman S, Yu Y, McMahon R, Richardson C. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia. Psychiatr Q 2006; 77: 81-95.
38. Wassef A, Dott S, Harris A, Brown A, O'Boyle M, Meyer W, et al. Randomized, placebocontrolled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. J Clin Psychopharmacol 2000; 20: 357-361.
39. Rybouchkin A, Kato Y, Tsunoda Y. Role of Histone Acetylation in Reprogramming of Somatic Nuclei Following Nuclear Transfer. Biol Reprod 2006; 74: 1083-1089.
40. Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotech 2008; 26: 795-797.
41. Han J, Sachdev PS, Sidhu KS. A combined epigenetic and non-genetic approach for reprogramming human somatic cells. PLoS One 2010; 5: e12297.
42. Araki R, Hoki Y, Uda M, Nakamura M, Jincho Y, Tamura C, Sunayama M, Ando S, Sugiura M, Yoshida MA, Kasama Y, Abe M. Crucial Role of c-Myc in the Generation of Induced Pluripotent Stem Cells. Stem Cells 2011; doi: 10.1002/ stem.685.
43. Kaichi S, Hasegawa K, Takaya T, Yokoo N, Mima T, Kawamura T, Morimoto T, Ono K, Baba S, Doi H, Yamanaka S, Nakahata T, Heike T. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc Res 2010; 88: 314-323.